Loading MedWatcher information…
Loading MedWatcher information…
FDA · FDA event 98475 · Posted Apr 29, 2026
insulin pump software versions 1.4.2, and 1.4.3 issue with Dexcom Continuous Glucose Monitoring (CGM) G7 sensor may result in delayed CGM reading then switch to non-CGM dosing, leading to only basal/requested meal doses provided, no correction doses/insulin reductions/suspensions for high/low glucose unless blood glucose entered for sensor life or replacement. Potential health risks to users include severe hyperglycemia with and without DKA and severe hypoglycemia.
The official notice takes precedence over this summary. Talk to your clinician before changing prescribed therapy.
| Model | Description | Lot / serial range | Manufactured | Status |
|---|---|---|---|---|
| Z-1996-2026 | Z-1996-2026 | Software versions 1.4.3, and 1.4.2 | Not provided in the normalized record | Ongoing |
Mar 12, 2026
Recall initiated
Date recorded by the FDA.
Apr 29, 2026
Posted by FDA
The recall event appeared in the FDA source.
Oct 8, 2026
Last checked
MedWatcher last reconciled this record with the openFDA export.